A research team led by Prof. Gu Hongcang and Zhang Fan from the Hefei Institutes of Physical Science of the Chinese Academy ...

Of 1.3 million participants in the MWS with a median follow-up of 21.4 years, 2,765 (o.21%) developed liver cancer, with no ...

Tumors are often genetic mosaics, harboring diverse cell populations shaped by mutations like copy number variations (CNVs). These genomic alterations ...

Professor Sa Kyung-ha's team at Korea University Medical School's medical informatics class found a new therapeutic target by ...

STAMPEDE otherwise follows a line of randomized trials (e.g., MAST, TAXOMET, IMPROVE) that have failed to prove cancer ...

This article explores the relationship between the immune system and cancer and outlines therapeutic strategies that leverage ...

The anti-GPC3 targeted therapies market is expected to witness growth in the coming years, driven by the increasing incidence of cancer cases, clinical pipeline activity, and anticipated regulatory ...

A massive meta-analysis shows staying active throughout adulthood can slash death risk by up to 40%. Learn why consistency matters more than perfection.

First Bispecific Antibody Drug Conjugates Commercial Approval Expected By 2029 Says Kuick Research. Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjug ...

DelveInsight's, “Gastrointestinal Stromal Tumors Pipeline Insight 2025” report provides comprehensive insights about 25+ ...

The independent meta-analysis assessed the overall predictive performance of the CP-GEP model, which demonstrated a high Sensitivity Rate (93%) and ...

Platelet-rich plasma therapy provided significant, durable relief of chronic noncancer pain, outperforming both corticosteroid and hyaluronic acid injections.